Latest News & Updates
Breaking News
4 hours ago
Simantini Singh Deo
Other trending news you may like to read
Rhythm Pharmaceuticals Appoints Kim Popovits To Board As Ed Mathers Steps Down After Years Of Leadership
Rhythm Pharmaceuticals appoints Kim Popovits to its Board as Ed Mathers steps down, strengthening leadership with commercialization expertise in rare neuroendocrine diseases.
Simantini Singh Deo
Denali Therapeutics Takes Full Control Of DNL593 After Takeda Ends Collaboration, Plans To Advance Therapy For Frontotemporal Dementia
Denali Therapeutics takes full control of DNL593 after Takeda exits collaboration, advancing progranulin therapy for frontotemporal dementia with Phase 1/2 results expected by 2026.
Simantini Singh Deo
Abeona Therapeutics Inc. Expands Access To ZEVASKYN As NewYork-Presbyterian/Columbia University Irving Medical Center Becomes Latest Qualified Treatment Center
Abeona Therapeutics expands ZEVASKYN access with new Qualified Treatment Center in New York, supporting gene therapy delivery for epidermolysis bullosa patients
Simantini Singh Deo
Annovis Bio Receives New U.S. Patent For Buntanetap To Prevent And Treat Brain Injuries Caused By Infections
Annovis Bio secures U.S. patent for buntanetap to prevent and treat infection-related brain injuries, expanding its neurodegenerative therapy program in Phase 3 development
Simantini Singh Deo
